Article
[Significance of the acetylator phenotype and initial oral/intravenous rifampicin administration in the treatment of tuberculosis].
Pneumologie (Stuttgart, Germany) - 1 Feb 1990
Loos U, Musch E, Schwabe H K
Abstract excerpt
In a pilot study involving 62 patients with open pulmonary tuberculosis, we established that slow acetyators and patients receiving intravenous rifampicin treatment showed a tendency towards a more rapid negativisation of the sputum culture than did fast acetyators (lower levels of isoniazid) or patients receiving oral rifampicin therapy (decreasing bioavailability of the rifampicin during treatment).
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
